Academic Bibliography

 Search 200 years of publications by Ghent University researchers.
Advanced search
1 file | 156.27 KB
Add to list
  1. Search results
  2. Efficacy of the combination of long-a...

Efficacy of the combination of long-acting release octreotide and tamoxifen in patients with advanced hepatocellular carcinoma: a randomised multicentre phase III study

G VERSET, C VERSLYPE, H REYNAERT, I BORBATH, P LANGLET, A VANDEBROEK, Marc Peeters (UGent) , G HOUBIERS, S FRANCQUE, M ARVANITAKIS, et al.
(2007) BRITISH JOURNAL OF CANCER. 97(5). p.582-588
Author
Organization

Downloads

  • Download
    Verset Br J Cancer 2007.pdf
    • full text
    • |
    • open access
    • |
    • PDF
    • |
    • 156.27 KB

Citation

Please use this url to cite or link to this publication:

MLA
VERSET, G., et al. “Efficacy of the Combination of Long-Acting Release Octreotide and Tamoxifen in Patients with Advanced Hepatocellular Carcinoma: A Randomised Multicentre Phase III Study.” BRITISH JOURNAL OF CANCER, vol. 97, no. 5, NATURE PUBLISHING GROUP, 2007, pp. 582–88, doi:1854/8930.
APA
VERSET, G., VERSLYPE, C., REYNAERT, H., BORBATH, I., LANGLET, P., VANDEBROEK, A., … VAN LAETHEM, J. (2007). Efficacy of the combination of long-acting release octreotide and tamoxifen in patients with advanced hepatocellular carcinoma: a randomised multicentre phase III study. BRITISH JOURNAL OF CANCER, 97(5), 582–588. https://doi.org/1854/8930
Chicago author-date
VERSET, G, C VERSLYPE, H REYNAERT, I BORBATH, P LANGLET, A VANDEBROEK, Marc Peeters, et al. 2007. “Efficacy of the Combination of Long-Acting Release Octreotide and Tamoxifen in Patients with Advanced Hepatocellular Carcinoma: A Randomised Multicentre Phase III Study.” BRITISH JOURNAL OF CANCER 97 (5): 582–88. https://doi.org/1854/8930.
Chicago author-date (all authors)
VERSET, G, C VERSLYPE, H REYNAERT, I BORBATH, P LANGLET, A VANDEBROEK, Marc Peeters, G HOUBIERS, S FRANCQUE, M ARVANITAKIS, and JL VAN LAETHEM. 2007. “Efficacy of the Combination of Long-Acting Release Octreotide and Tamoxifen in Patients with Advanced Hepatocellular Carcinoma: A Randomised Multicentre Phase III Study.” BRITISH JOURNAL OF CANCER 97 (5): 582–588. doi:1854/8930.
Vancouver
1.
VERSET G, VERSLYPE C, REYNAERT H, BORBATH I, LANGLET P, VANDEBROEK A, et al. Efficacy of the combination of long-acting release octreotide and tamoxifen in patients with advanced hepatocellular carcinoma: a randomised multicentre phase III study. BRITISH JOURNAL OF CANCER. 2007;97(5):582–8.
IEEE
[1]
G. VERSET et al., “Efficacy of the combination of long-acting release octreotide and tamoxifen in patients with advanced hepatocellular carcinoma: a randomised multicentre phase III study,” BRITISH JOURNAL OF CANCER, vol. 97, no. 5, pp. 582–588, 2007.
@article{414223,
  author       = {{VERSET, G and VERSLYPE, C and REYNAERT, H and BORBATH, I and LANGLET, P and VANDEBROEK, A and Peeters, Marc and HOUBIERS, G and FRANCQUE, S and ARVANITAKIS, M and VAN LAETHEM, JL}},
  issn         = {{0007-0920}},
  journal      = {{BRITISH JOURNAL OF CANCER}},
  language     = {{eng}},
  number       = {{5}},
  pages        = {{582--588}},
  publisher    = {{NATURE PUBLISHING GROUP}},
  title        = {{Efficacy of the combination of long-acting release octreotide and tamoxifen in patients with advanced hepatocellular carcinoma: a randomised multicentre phase III study}},
  url          = {{http://doi.org/1854/8930}},
  volume       = {{97}},
  year         = {{2007}},
}
Altmetric
View in Altmetric
Web of Science
Times cited: